Published online in Biomedical Computation Review on June 3, 2015.  Biomedical Computation Review is published by the Mobilize Center, through the NIH Big Data to Knowledge (BD2K) program.

Origent CEO Mike Keymer comments on the┬ácompany’s work supporting ALS clinical trials through the development of virtual placebo control arms.

This article is accessible on-line at www.BiomedicalComputationReview.com, as shown below:

 

Pin It on Pinterest

Share This